Guidance for industry, q & a : content and format of INDs for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products.
| Other author | Center for Drug Evaluation and Research (U.S.) |
| Other author | Center for Biologics Evaluation and Research (U.S.) |
| Format | Electronic |
| Publication Info | Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research : Center for Biologics Evaluation and Research, [2000] |
| Description | 1 online resource ([4] p.) |
| Supplemental Content | https://purl.fdlp.gov/GPO/LPS119805 |
| Subjects |
| Variant title | Guidance for industry, questions and answers |
| Portion of title | Content and format of INDs for phase 1 studies of drugs, including well-characterized, therapeutic, biotechnology-derived products. |
| General note | "Pharmacology/toxicology." |
| General note | "October 2000." |
| General note | GPO Cataloging Record Distribution Program (CRDP). |
| GPO item number | 0499-T (online) |
| Govt. docs number | HE 20.4702:IN 8/7 HE 20.4702:IN 8/2 |
Availability
| Library | Location | Call Number | Status | Item Actions |
|---|---|---|---|---|
| Electronic Resources | Access Content Online | ✔ Available |